Daliresp
Daliresp is roflumilast 500mg film-coated tablets for chronic obstructive pulmonary disease. A PDE4 inhibitor, so anti-inflammatory rather than bronchodilating.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 500mg | 30 tablets | $58.50 | $1.95 |
| 500mg | 60 tablets | $93.60 | $1.56 |
| 500mg | 90 tablets | $120.60 | $1.34 |
| 500mg | 120 tablets | $140.40 | $1.17 |
| 500mg | 180 tablets | $187.20 | $1.04 |
- Category
- Respiratory Health
- Active ingredient
- Roflumilast
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 500mg
You will receive a quality generic equivalent, depending on stock.
No prescription needed: we place your order for Daliresp on your behalf.
- Alternative names
- Daxas
- Therapeutic class
- Phosphodiesterase-4 Inhibitor
- Pharmacological class
- PDE4 Inhibitor
- Minor side effects
- diarrhoea; nausea; weight loss; abdominal pain
- Moderate side effects
- headache; insomnia; anxiety
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Originator
- AstraZeneca
- Onset time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature in a dry place.
- Drug interactions
- rifampicin; phenobarbital; carbamazepine; phenytoin
- Age restrictions
- Not for use in those under 18 years.
- Pregnancy and breastfeeding
- Pregnancy: Avoid. Breastfeeding: Avoid.
Contraindications
hypersensitivity; moderate to severe hepatic impairment; severe immunological diseases; severe acute infectious diseases
Precautions and warnings
monitor weight regularly; use with caution in history of depression; discontinue if suicidal ideation occurs
Serious side effects
suicidal ideation, requires immediate medical attention; severe depression, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
Daliresp is roflumilast 500mg film-coated tablets for chronic obstructive pulmonary disease. A PDE4 inhibitor, so anti-inflammatory rather than bronchodilating.
Mechanism of action
This medicine inhibits phosphodiesterase-4, an enzyme involved in inflammatory processes, reducing inflammation in the airways to improve breathing in chronic respiratory conditions.
Daliresp contains Roflumilast, a medication used to reduce the risk of exacerbations in patients with Chronic Obstructive Pulmonary Disease. The same active ingredient is also sold under the brand name Daxas. Daliresp is supplied as a tablet in a strength of 500mg.
Buying Daliresp online
Generic Roflumilast is often more affordable than the original brand.
What you will receive
Daliresp is the originator brand name, made by AstraZeneca. We use it here to identify the medicine only; we are not affiliated with AstraZeneca and do not ship the original Daliresp.
- You receive a generic equivalent: the same active ingredient (Roflumilast) at the same dose, mostly recognised branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- Inactive ingredients, tablet appearance and packaging can differ from the original brand; the active ingredient and dose are the same.